Sonic Healthcare Ltd

Price Chart

Risk-Adjusted Performance

Also Listed On

Sonic Healthcare Ltd (SHL) Price Performance

Sonic Healthcare Ltd (SHL) trades on Australian Securities Exchange in AUD. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at AUD19.65, down 2.09% from the previous close.

Over the past year, SHL has traded between a low of AUD19.65 and a high of AUD28.16. The stock has lost 21.9% over this period. It is currently 30.2% below its 52-week high.

Sonic Healthcare Ltd has a market capitalization of $10.28B, with a price-to-earnings ratio of 18.73 and a dividend yield of 5.21%.

About Sonic Healthcare Ltd

Sonic Healthcare Limited offers medical diagnostic services, and administrative services and facilities to medical practitioners in Australia, the United States, Germany, and internationally. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. It also offers primary care medical services comprising general practice clinics, occupational health services, skin cancer clinics, general practice IT solutions, and community-based healthcare services, as well as clinical trials services. Sonic Healthcare Limited was incorporated in 1934 and is headquartered in Sydney, Australia.